Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Peter Forsyth
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Living Beings
Concepts & Ideas
Anatomy
Chemicals & Drugs
Sign-in to see full Profile
Network (preview)
19
Brasher, P M A
16
Cairncross, Gregory
16
Senger, Donna
12
Rewcastle, Barry
12
Johnston, Randal
11
Muzik, Huong
9
Lun, Xueqing
9
Edwards, Dylan
8
Alain, Tommy
8
Lee, Patrick
7
Hamilton, Mark
7
DeAngelis, Lisa
6
Fulton, Dorcas
6
Parney, Ian
5
Paleologos, Nina
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Peter Forsyth (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Roldán Gloria B; Scott James N; McIntyre John B; Dharmawardene Marisa; de Robles Paula A; Magliocco Anthony M; Yan Elizabeth S Y; Parney Ian F; Forsyth Peter A; Cairncross J Gregory; Hamilton Mark G; Easaw Jacob C
Population-based study of pseudoprogression after chemoradiotherapy in GBM.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2009;36(5):617-22.
-
2009: Kelly John J P; Stechishin Owen; Chojnacki Andrew; Lun Xueqing; Sun Beichen; Senger Donna L; Forsyth Peter; Auer Roland N; Dunn Jeff F; Cairncross J Gregory; Parney Ian F; Weiss Samuel
Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.
Stem cells (Dayton, Ohio) 2009;27(8):1722-33.
-
2009: Lun Xue Qing; Jang Ji-Hyun; Tang Nan; Deng Helen; Head Renee; Bell John C; Stojdl David F; Nutt Catherine L; Senger Donna L; Forsyth Peter A; McCart J Andrea
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2777-88.
-
2008: de Robles Paula; McIntyre John; Kalra Sanjog; Roldán Gloria; Cairncross Gregory; Forsyth Peter; Magliocco Tony; Hamilton Mark; Easaw Jacob
Methylation status of MGMT gene promoter in meningiomas.
Cancer genetics and cytogenetics 2008;187(1):25-7.
-
2008: Mohile Nimish A; Forsyth Peter; Stewart Douglas; Raizer Jeffrey J; Paleologos Nina; Kewalramani Tarun; Louis David N; Cairncross J Gregory; Abrey Lauren E
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.
Journal of neuro-oncology 2008;89(2):187-93.
-
2008: Sijben Angelique E; McIntyre John B; Roldán Gloria B; Easaw Jacob C; Yan Elizabeth; Forsyth Peter A; Parney Ian F; Magliocco Anthony M; Bernsen Hans; Cairncross J Gregory
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.
Journal of neuro-oncology 2008;89(1):97-103.
-
2008: Roldán Gloria; Brasher Penny; Vecil Giacomo; Senger Donna; Rewcastle Barry; Cairncross Gregory; Forsyth Peter; Hamilton Mark
Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2008;35(2):210-5.
-
2008: Roldán Gloria; Scott James; George David; Parney Ian; Easaw Jacob; Cairncross Gregory; Forsyth Peter; Yan Elizabeth
Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2008;35(2):204-9.
-
2008: Brown Robert; Zlatescu Magdalena; Sijben Angelique; Roldan Gloria; Easaw Jay; Forsyth Peter; Parney Ian; Sevick Robert; Yan Elizabeth; Demetrick Douglas; Schiff David; Cairncross Gregory; Mitchell Ross
The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendroglioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(8):2357-62.
-
2008: Forsyth Peter; Roldán Gloria; George David; Wallace Carla; Palmer Cheryl Ann; Morris Don; Cairncross Gregory; Matthews Maureen Vallee; Markert James; Gillespie Yancey; Coffey Matt; Thompson Brad; Hamilton Mark
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(3):627-32.
-
2008: Wu Yushui; Lun Xueqing; Zhou Hongyuan; Wang Limei; Sun Beichen; Bell John C; Barrett John W; McFadden Grant; Biegel Jaclyn A; Senger Donna L; Forsyth Peter A
Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):1218-27.
-
2007: Barrett John W; Alston Lindsay R; Wang Fuan; Stanford Marianne M; Gilbert Philippe-Alexandre; Gao Xiujuan; Jimenez June; Villeneuve Danielle; Forsyth Peter; McFadden Grant
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.
Journal of neurovirology 2007;13(6):549-60.
-
2007: Alain T; Wong J F; Endersby R; Urbanski S J; Lee P W; Muruve D A; Johnston R N; Forsyth P A; Beck P L
Reovirus decreases azoxymethane-induced aberrant crypt foci and colon cancer in a rodent model.
Cancer gene therapy 2007;14(10):867-72.
-
2007: Lun Xue Qing; Zhou Hongyuan; Alain Tommy; Sun Beichen; Wang Limei; Barrett John W; Stanford Marianne M; McFadden Grant; Bell John; Senger Donna L; Forsyth Peter A
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.
Cancer research 2007;67(18):8818-27.
-
2007: Johnston Angela L M; Lun Xueqing; Rahn Jennifer J; Liacini Abdelhamid; Wang Limei; Hamilton Mark G; Parney Ian F; Hempstead Barbara L; Robbins Stephen M; Forsyth Peter A; Senger Donna L
The p75 neurotrophin receptor is a central regulator of glioma invasion.
PLoS biology 2007;5(8):e212.
-
2007: Mauer M; Stupp R; Taphoorn M J B; Coens C; Osoba D; Marosi C; Wong R; de Witte O; Cairncross J G; Efficace F; Mirimanoff R O; Forsyth P; van den Bent M J; Weller M; Bottomley A
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.
British journal of cancer 2007;97(3):302-7.
-
2007: Alain Tommy; Kim Tom Sy; Lun Xueqing; Liacini Adelhamid; Schiff Leslie A; Senger Donna L; Forsyth Peter A
Proteolytic disassembly is a critical determinant for reovirus oncolysis.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(8):1512-21.
-
2007: Kim M; Egan C; Alain T; Urbanski S J; Lee P W; Forsyth P A; Johnston R N
Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells.
Oncogene 2007;26(28):4124-34.
-
2007: Power Anthony T; Wang Jiahu; Falls Theresa J; Paterson Jennifer M; Parato Kelley A; Lichty Brian D; Stojdl David F; Forsyth Peter A J; Atkins Harry; Bell John C
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(1):123-30.
-
2006: Lun XueQing; Senger Donna L; Alain Tommy; Oprea Andra; Parato Kelley; Stojdl Dave; Lichty Brian; Power Anthony; Johnston Randal N; Hamilton Mark; Parney Ian; Bell John C; Forsyth Peter A
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
Journal of the National Cancer Institute 2006;98(21):1546-57.
-
2006: Alain T; Kim M; Johnston R N; Urbanski S; Kossakowska A E; Forsyth P A; Lee P W K
The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro.
British journal of cancer 2006;95(8):1020-7.
-
2006: Tang P; Roldan G; Brasher P M A; Fulton D; Roa W; Murtha A; Cairncross J G; Forsyth P A
A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
Journal of neuro-oncology 2006;78(3):311-6.
-
2006: Abrey Lauren E; Childs Barrett H; Paleologos Nina; Kaminer Lynne; Rosenfeld Steven; Salzman Donna; Finlay Jonathan L; Gardner Sharon; Peterson Kendra; Hu Wendy; Swinnen Lode; Bayer Robert; Forsyth Peter; Stewart Douglas; Smith Anne M; Macdonald David R; Weaver Susan; Ramsay David A; Nimer Stephen D; DeAngelis Lisa M; Cairncross J Gregory
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
Neuro-oncology 2006;8(2):183-8.
-
2006: Moss Erin L; Simpson J Steven A; Pelletier Guy; Forsyth Peter
An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners.
Psycho-oncology 2006;15(3):259-67.
-
2005: Taphoorn Martin J B; Stupp Roger; Coens Corneel; Osoba David; Kortmann Rolf; van den Bent Martin J; Mason Warren; Mirimanoff René O; Baumert Brigitta G; Eisenhauer Elizabeth; Forsyth Peter; Bottomley Andrew;
Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
The lancet oncology 2005;6(12):937-44.
-
2005: Parato Kelley A; Senger Donna; Forsyth Peter A J; Bell John C
Recent progress in the battle between oncolytic viruses and tumours.
Nature reviews. Cancer 2005;5(12):965-76.
-
2005: Zhou Yan; Zhang Jing; Liu Qiang; Bell Robert; Muruve Daniel A; Forsyth Peter; Arcellana-Panlilio Mayi; Robbins Stephen; Yong V Wee
The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.
Carcinogenesis 2005;26(12):2058-68.
-
2005: Lun Xueqing; Yang Wenqing; Alain Tommy; Shi Zhong-Qiao; Muzik Huong; Barrett John W; McFadden Grant; Bell John; Hamilton Mark G; Senger Donna L; Forsyth Peter A
Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.
Cancer research 2005;65(21):9982-90.
-
2005: Thirukkumaran C M; Luider J M; Stewart D A; Alain T; Russell J A; Auer I A; Forsyth P; Morris D G
Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts.
Bone marrow transplantation 2005;35(11):1055-64.
-
2005: Kirby Sarah; Gertler Stan Z; Mason Warren; Watling Christopher; Forsyth Peter; Aniagolu Jacinta; Stagg Robert; Wright Matthew; Powers Jean; Eisenhauer Elizabeth A
Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group.
Neuro-oncology 2005;7(2):183-8.
-
2004: Yang Wen Qing; Lun Xueqing; Palmer Cheryl Ann; Wilcox M Elizabeth; Muzik Huong; Shi Zhong Qiao; Dyck Richard; Coffey Matt; Thompson Brad; Hamilton Mark; Nishikawa Sandra G; Brasher Penny M A; Fonseca Kevin; George David; Rewcastle N Berry; Johnston Randal N; Stewart Doug; Lee Patrick W K; Senger Donna L; Forsyth Peter A
Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8561-76.
-
2004: Yang W Q; Senger D L; Lun X Q; Muzik H; Shi Z Q; Dyck R H; Norman K; Brasher P M A; Rewcastle N B; George D; Stewart D; Lee P W K; Forsyth P A
Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer.
Gene therapy 2004;11(21):1579-89.
-
2004: Megyesi Joseph F; Kachur Edward; Lee Donald H; Zlatescu Magdalena C; Betensky Rebecca A; Forsyth Peter A; Okada Yoshifumi; Sasaki Hikaru; Mizoguchi Masahiro; Louis David N; Cairncross J Gregory
Imaging correlates of molecular signatures in oligodendrogliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4303-6.
-
2004: Roa W; Brasher P M A; Bauman G; Anthes M; Bruera E; Chan A; Fisher B; Fulton D; Gulavita S; Hao C; Husain S; Murtha A; Petruk K; Stewart D; Tai P; Urtasun R; Cairncross J G; Forsyth P
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1583-8.
-
2004: Fallon Kenneth B; Palmer Cheryl A; Roth Kevin A; Nabors L Burton; Wang Wenquan; Carpenter Mark; Banerjee Ruma; Forsyth Peter; Rich Keith; Perry Arie
Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.
Journal of neuropathology and experimental neurology 2004;63(4):314-22.
-
2003: Vieyra Diego; Senger Donna L; Toyama Tatsuya; Muzik Huong; Brasher Penny M A; Johnston Randal N; Riabowol Karl; Forsyth Peter A;
Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5952-61.
-
2003: Abrey Lauren E; Childs Barrett H; Paleologos Nina; Kaminer Lynne; Rosenfeld Steven; Salzman Donna; Finlay Jonathan L; Gardner Sharon; Peterson Kendra; Hu Wendy; Swinnen Lode; Bayer Robert; Forsyth Peter; Stewart Douglas; Smith Anne M; Macdonald David R; Weaver Susan; Ramsey David A; Nimer Stephen D; DeAngelis Lisa M; Cairncross J Gregory
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.
Journal of neuro-oncology 2003;65(2):127-34.
-
2003: Abrey Lauren E; Moskowitz Craig H; Mason Warren P; Crump Michael; Stewart Douglas; Forsyth Peter; Paleologos Nina; Correa Denise D; Anderson Nicole D; Caron Dawn; Zelenetz Andrew; Nimer Stephen D; DeAngelis Lisa M
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4151-6.
-
2003: Bélanger Karl; MacDonald David; Cairncross Gregory; Gertler Stan; Forsyth Peter; Burdette-Radoux Susan; Bergeron Julie; Soulières Denis; Ludwin Samuel; Wainman Nancy; Eisenhauer Elizabeth
A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma.
Investigational new drugs 2003;21(4):473-80.
-
2003: Yang Wen Qing; Senger Donna; Muzik Huong; Shi Zhong Qiao; Johnson Denise; Brasher Penny M A; Rewcastle N Barry; Hamilton Mark; Rutka Jim; Wolff Johannes; Wetmore Cynthia; Curran Tom; Lee Patrick W K; Forsyth Peter A
Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma.
Cancer research 2003;63(12):3162-72.
-
2003: Senger Donna; Cairncross J Gregory; Forsyth Peter A J
Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype?
Cancer journal (Sudbury, Mass.) 2003;9(3):214-21.
-
2003: Forsyth Peter A; Weaver Susan; Fulton Dorcas; Brasher Penelope M A; Sutherland Garnette; Stewart Doug; Hagen Neil A; Barnes Penny; Cairncross J Greg; DeAngelis Lisa M
Prophylactic anticonvulsants in patients with brain tumour.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2003;30(2):106-12.
-
2003: Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell J A; Stewart D A
High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
Bone marrow transplantation 2003;31(8):679-85.
-
2003: Nuttall Robert K; Pennington Caroline J; Taplin Jennifer; Wheal Alison; Yong Voon Wee; Forsyth Peter A; Edwards Dylan R
Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.
Molecular cancer research : MCR 2003;1(5):333-45.
-
2002: Zia M I; Forsyth P; Chaudhry A; Russell J; Stewart D A
Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.
Bone marrow transplantation 2002;30(9):565-9.
-
2002: Scott J N; Brasher P M A; Sevick R J; Rewcastle N B; Forsyth P A
How often are nonenhancing supratentorial gliomas malignant? A population study.
Neurology 2002;59(6):947-9.
-
2001: Groft L L; Muzik H; Rewcastle N B; Johnston R N; Knäuper V; Lafleur M A; Forsyth P A; Edwards D R
Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.
British journal of cancer 2001;85(1):55-63.
-
2001: Wilcox M E; Yang W; Senger D; Rewcastle N B; Morris D G; Brasher P M; Shi Z Q; Johnston R N; Nishikawa S; Lee P W; Forsyth P A
Reovirus as an oncolytic agent against experimental human malignant gliomas.
Journal of the National Cancer Institute 2001;93(12):903-12.
-
2001: Lafleur M A; Forsyth P A; Atkinson S J; Murphy G; Edwards D R
Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
Biochemical and biophysical research communications 2001;282(2):463-73.
-
2001: Wong H; Muzik H; Groft L L; Lafleur M A; Matouk C; Forsyth P A; Schultz G A; Wall S J; Edwards D R
Monitoring MMP and TIMP mRNA expression by RT-PCR.
Methods in molecular biology (Clifton, N.J.) 2001;151():305-20.
-
2000: Raithatha S A; Muzik H; Muzik H; Rewcastle N B; Johnston R N; Edwards D R; Forsyth P A
Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas.
Neuro-oncology 2000;2(3):145-50.
-
2000: Cairncross G; Swinnen L; Bayer R; Rosenfeld S; Salzman D; Paleologos N; Kaminer L; Forsyth P; Stewart D; Peterson K; Hu W; Macdonald D; Ramsay D; Smith A;
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Neuro-oncology 2000;2(2):114-9.
-
2000: Gertler S Z; MacDonald D; Goodyear M; Forsyth P; Stewart D J; Belanger K; Perry J; Fulton D; Steward W; Wainman N; Seymour L
NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):315-8.
-
1999: Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
Suppression of ING1 expression in sporadic breast cancer.
Oncogene 1999;18(37):5187-93.
-
1999: Scott J N; Rewcastle N B; Brasher P M; Fulton D; MacKinnon J A; Hamilton M; Cairncross J G; Forsyth P
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study.
Annals of neurology 1999;46(2):183-8.
-
1999: Price A; Shi Q; Morris D; Wilcox M E; Brasher P M; Rewcastle N B; Shalinsky D; Zou H; Appelt K; Johnston R N; Yong V W; Edwards D; Forsyth P
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):845-54.
-
1999: Forsyth P A; Wong H; Laing T D; Rewcastle N B; Morris D G; Muzik H; Leco K J; Johnston R N; Brasher P M; Sutherland G; Edwards D R
Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
British journal of cancer 1999;79(11-12):1828-35.
-
1999: Frölichsthal-Schoeller P; Vescovi A L; Krekoski C A; Murphy G; Edwards D R; Forsyth P
Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells.
Neuroreport 1999;10(2):345-51.
-
1999: Verhoef M J; Hagen N; Pelletier G; Forsyth P
Alternative therapy use in neurologic diseases: use in brain tumor patients.
Neurology 1999;52(3):617-22.
-
1999: Hao D; DiFrancesco L M; Brasher P M; deMetz C; Fulton D S; DeAngelis L M; Forsyth P A
Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):65-70.
-
1998: Coffey M C; Strong J E; Forsyth P A; Lee P W
Reovirus therapy of tumors with activated Ras pathway.
Science (New York, N.Y.) 1998;282(5392):1332-4.
-
1998: Scott J N; Rewcastle N B; Brasher P M; Fulton D; Hagen N A; MacKinnon J A; Sutherland G; Cairncross J G; Forsyth P
Long-term glioblastoma multiforme survivors: a population-based study.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1998;25(3):197-201.
-
1998: Yong V W; Krekoski C A; Forsyth P A; Bell R; Edwards D R
Matrix metalloproteinases and diseases of the CNS.
Trends in neurosciences 1998;21(2):75-80.
-
1998: Forsyth P A; Laing T D; Gibson A W; Rewcastle N B; Brasher P; Sutherland G; Johnston R N; Edwards D R
High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma.
Journal of neuro-oncology 1998;36(1):21-9.
-
1997: Forsyth P A; Balmaceda C; Peterson K; Seidman A D; Brasher P; DeAngelis L M
Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing.
Journal of neuro-oncology 1997;35(1):47-53.
-
1997: Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins R B; Lassam N J; Hogg D
Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(6):977-81.
-
1997: Forsyth P A; Dalmau J; Graus F; Cwik V; Rosenblum M K; Posner J B
Motor neuron syndromes in cancer patients.
Annals of neurology 1997;41(6):722-30.
-
1997: Forsyth P A; Petrov E; Mahallati H; Cairncross J G; Brasher P; MacRae M E; Hagen N A; Barnes P; Sevick R J
Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):2076-81.
-
1996: Forsyth P A; DeAngelis L M
Biology and management of AIDS-associated primary CNS lymphomas.
Hematology/oncology clinics of North America 1996;10(5):1125-34.
-
1996: Meckling S; Dold O; Forsyth P A; Brasher P; Hagen N A
Malignant supratentorial glioma in the elderly: is radiotherapy useful?
Neurology 1996;47(4):901-5.
-
1996: Forsyth P A; Cairncross J G
Chemotherapy for malignant gliomas.
Baillière's clinical neurology 1996;5(2):371-93.
-
1996: Macdonald D; Cairncross G; Stewart D; Forsyth P; Sawka C; Wainman N; Eisenhauer E
Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):205-7.
-
1996: Fulton D; Urtasun R; Forsyth P
Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.
Journal of neuro-oncology 1996;27(2):149-55.
-
1996: Forsyth P; Cairncross G; Stewart D; Goodyear M; Wainman N; Eisenhauer E
Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group.
Investigational new drugs 1996;14(2):203-6.
-
1995: Forsyth P A; Cairncross J G
Treatment of malignant glioma in adults.
Current opinion in neurology 1995;8(6):414-8.
-
1994: Forsyth P A; Yahalom J; DeAngelis L M
Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS.
Neurology 1994;44(8):1473-9.
-
1994: Peterson K; Forsyth P A; Posner J B
Paraneoplastic sensorimotor neuropathy associated with breast cancer.
Journal of neuro-oncology 1994;21(2):159-70.
-
1993: Forsyth P A; Posner J B
Headaches in patients with brain tumors: a study of 111 patients.
Neurology 1993;43(9):1678-83.
Sign-in to see more
